Literature DB >> 13316756

The action of cytotoxic antisera on the HeLa strain of human carcinoma.

D G MILLER, T C HSU.   

Abstract

Entities:  

Keywords:  IMMUNE SERUMS/effects; NEOPLASMS/experimental

Mesh:

Substances:

Year:  1956        PMID: 13316756

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  A STUDY ON THE ANTIGENICITY OF A HUMAN CELL LINE PROPAGATED IN A HETEROLOGOUS MEDIUM.

Authors:  G J SWAEN
Journal:  Experientia       Date:  1963-12-15

Review 2.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

3.  [Cytolysis of tumor cells in vitro with antiserum].

Authors:  V Kinzel
Journal:  Z Krebsforsch       Date:  1966

4.  The heterocytotoxicity of human serum. III. Studies of the serum levels and distribution of activity in human populations.

Authors:  G Glumac; A Mates; D Eidinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

Review 5.  Synthesis of lipids or lipid-containing macromolecules in tumor cells. Relevance to host defense.

Authors:  S H Ohanian
Journal:  Surv Immunol Res       Date:  1983

6.  A cellular reaction to antibody in tissue culture studied with electron microscopy.

Authors:  H LATTA
Journal:  J Biophys Biochem Cytol       Date:  1959-05-25

7.  Studies on immune cellular injury. I. Cytotoxic effects of antibody and complement.

Authors:  A ROSS; I H LEPOW
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

8.  The antigenic composition of mouse ascites tumour cells using in vitro and gel-diffusion techniques.

Authors:  G C EASTY; E J AMBROSE
Journal:  Br J Cancer       Date:  1957-06       Impact factor: 7.640

9.  The cytotoxic action of immune gamma globulin and complement on Krebs ascites tumor cells. I. Ultrastructural studies.

Authors:  B GOLDBERG; H GREEN
Journal:  J Exp Med       Date:  1959-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.